With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Pharma giant targets new standards of care
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
